← Open Payments lookup

MICHAEL FLORES: Open Payments

NPI 1427503515 · LYNWOOD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$17,094 in 341 payments from 39 companies in 2025. Trend: 2023 $22,854 · 2024 $19,313 · 2025 $17,094

Food & beverage: $10,197Speaker / faculty: $2,368Travel & lodging: $1,647Speaker / faculty: $1,620Consulting: $1,261
CompanyPaymentsAmount
Madrigal Pharmaceuticals33$2,896
Dexcom, Inc.5$2,819
Amgen Inc.31$2,111
Medtronic, Inc.9$1,533
AstraZeneca Pharmaceuticals LP21$1,151
ABBVIE INC.40$1,042
Ardelyx, Inc.14$770
Salix Pharmaceuticals, a division of Bausch Health US, LLC27$556
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)11$522
PFIZER INC.19$367

Products named: REZDIFFRA, DEXCOM G7 GSS (161), REPATHA, MINIMED 780G, IBSRELA, CAPLYTA, AIRSUPRA, XIFAXAN.

Industry payments across CA — which companies pay providers there.